1. Home
  2. MTRX vs ELDN Comparison

MTRX vs ELDN Comparison

Compare MTRX & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Matrix Service Company

MTRX

Matrix Service Company

HOLD

Current Price

$10.84

Market Cap

361.0M

ML Signal

HOLD

Logo Eledon Pharmaceuticals Inc.

ELDN

Eledon Pharmaceuticals Inc.

HOLD

Current Price

$3.21

Market Cap

291.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTRX
ELDN
Founded
1984
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
361.0M
291.8M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
MTRX
ELDN
Price
$10.84
$3.21
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$17.00
$8.50
AVG Volume (30 Days)
188.2K
872.7K
Earning Date
05-06-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
30.67
EPS
N/A
N/A
Revenue
$769,286,000.00
N/A
Revenue This Year
$19.75
N/A
Revenue Next Year
$7.96
N/A
P/E Ratio
N/A
N/A
Revenue Growth
5.64
N/A
52 Week Low
$9.88
$1.35
52 Week High
$15.97
$4.60

Technical Indicators

Market Signals
Indicator
MTRX
ELDN
Relative Strength Index (RSI) 36.92 35.97
Support Level $10.79 $2.68
Resistance Level $12.48 $4.21
Average True Range (ATR) 0.30 0.16
MACD -0.04 -0.03
Stochastic Oscillator 17.75 4.13

Price Performance

Historical Comparison
MTRX
ELDN

About MTRX Matrix Service Company

Matrix Service Co provides engineering, fabrication, construction, maintenance, and repair services prominently to the energy and industrial markets. The company operates through three main segments: Storage and Terminal Solutions, Utility and Power Infrastructure, and Process and Industrial Facilities. These segments cover services like building and maintaining storage tanks and terminals, supporting power delivery and new power generation projects including renewables, as well as plant maintenance and turnarounds for refining and petrochemical industries. Matrix generates revenue by delivering these services to clients in oil, gas, power, and petrochemical sectors across North America and internationally.

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.

Share on Social Networks: